Gene synthesis market is predicted to reach USD 11.23 billion at a CAGR of 19.96% during the forecast period 2023-2032

Market Research Future (MRFR) has published on the “Global Gene synthesis market”.

The gene synthesis market is estimated to register a CAGR of 19.96% during the forecast period of 2023 to 2032.

MRFR recognizes the following companies as the key players in the global gene synthesis market— gene synthesis market are Thermo Fisher Scientific, Inc. (US), Lonza (Switzerland), Catalent, Inc., WuXi Biologics (China), Samsung Biologics (South Korea), Siegfried Holding AG (Switzerland), Fujifilm Diosynth Biotechnologies (US), Recipharm AB (Sweden), Boehringer Ingelheim International GmbH (Germany), and Merck KGaA (Germany).

Market Highlights

The global gene synthesis market is accounted for to register a CAGR of 19.96% during the forecast period and is estimated to reach USD 11.23 billion by 2032.

The global gene synthesis market is driven by several factors such as increased prevalence of genetic disorders and chronic disease and increasing R&D in the field of genomics and next-generation sequencing. The World Health Organization (WHO) estimates that 400 million people worldwide suffer from genetic disorders. Huntington's disease, sickle cell anemia, cystic fibrosis, and hereditary cancers are a few prevalent genetic illnesses. As per the World Health Organization, 71% of global deaths are attributed to chronic diseases. Furthermore, government and academic research organizations employ these services for their genomics and genetic engineering projects which boost the growth of the market. However, the complex gene synthesis techniques and high process cost is anticipated to hamper market growth.

Access full report @ https://www.marketresearchfuture.com/reports/gene-synthesis-market-11624

Segment Analysis

The global gene synthesis market has been segmented based on method, services, application, and end user.

On the basis of Method, the market is segmented into solid-phase synthesis, chip-based DNA synthesis, and PCR based enzyme synthesis. The solid-phase synthesis segment was attributed to holding the largest market share in 2022 revenue as estimated by MRFR analysts. This is due to the Solid-phase synthesis is increasingly utilized to generate canonical and modified polymers of nucleic acids, specifically DNA or RNA, making widely used technology in a variety of fields and research goals.

Further, we estimate that the market segment will continue to pool in the largest chunk of revenue during the forecast period. It has been identified that the segment market yet witnesses continuous innovations and movements in terms of new product launches.

Based on services, the market has been segmented into Antibody DNA Synthesis, Viral DNA synthesis, regulatory support services, bioassay services, process development services, and others. The Antibody DNA synthesis segment held the largest segment in 2022. It is attributed to Antibody DNA synthesis is used to produce synthetic genes encoding for specific antibodies, which are then used in a variety of applications such as diagnostics, therapeutics, and research tools.

Based on Application, the market has been segmented into gene & cell therapy development, vaccine development, and disease diagnosis. The gene & cell therapy development segment held the largest segment in 2022. Gene and cell therapy development is one of the most promising applications of gene synthesis and is rapidly expanding due to recent advancements in genome editing technology.

On the basis of the end user, the market is segmented into biopharmaceutical companies, academic and research institutes, and contract research organizations. The Academic and research institutes segment is projected to have the largest market share during the forecast period.

Regional Analysis

The global gene synthesis market, based on region, has been divided into North America, Europe, Asia-Pacific, and the Rest of the World. North America consists of the US and Canada. The Europe gene synthesis market comprises Germany, France, the UK, Italy, Spain, and the rest of Europe. The gene synthesis market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World gene synthesis market comprises of Middle East, Africa, and Latin America.

The increasing demand for targeted and personalized medicine, and favorable government initiatives in North America, are boosting the growth of the North American region.

Moreover, the Europe market has been persistently growing owing to the growing gene synthesis use in creating tailored medications and expanding applications of the method in synthetic biology in the region.

Additionally, market factors, such as rising interest in synthetic biology research as well as expanding research efforts to create efficient treatments in the region in the Asia-Pacific region are driving the region’s growth. Moreover, China’s market of gene synthesis is expected to hold the largest market share, and India market of gene synthesis is expected fastest-growing market in the Asia-Pacific region.

Furthermore, the rest of the World gene synthesis market is divided into the Middle East, Africa, and Latin America. The main factors influencing the growth of gene synthesis in the Middle East and Africa are the expanding research activities and biotechnology endeavors in the region that boost the market growth in the Middle East. On the other hand, the growth opportunities in developing countries such as South Africa, UAE, and Saudi Arabia are estimated to provide lucrative growth opportunities to the market players.

Key Findings of the Study

• The global gene synthesis market is expected to reach USD 11.23 billion by 2032, at a CAGR of 19.96% during the forecast period.


• The Asia-Pacific region accounted for the fastest-growing global market, owing to the rising interest in synthetic biology research as well as expanding research efforts to create efficient treatments in the Asia-Pacific region.


• Based on this method, the solid-phase synthesis segment was attributed to holding the largest market in 2022, with an approximate market share of 45–65%.


• Gene synthesis market are Thermo Fisher Scientific, Inc (US), Lonza (Switzerland), Catalent, Inc (US), WuXi Biologics (China), Samsung Biologics (South Korea) Siegfried Holding AG (Switzerland) Fujifilm Diosynth Biotechnologies (US) Recipharm AB (Sweden) Boehringer Ingelheim International GmbH (Germany) Merck KGaA (Germany) are the key market players.